Earlier this month, the Food and Drug Administration declined to approve MDMA-assisted therapy for PTSD. Concerns over the clinical research and questions about whether the benefits outweighed the risks factored into the decision.
But along with the FDA’s rejection of MDMA therapy, there have been allegations of “unethical conduct,” including sexual abuse on the part of an unlicensed therapist at one of the trial sites. The allegations have raised questions about the therapy component of the treatment and a practice known as “nurturing touch.”
On Cincinnati Edition, we discuss the FDA decision, what it means for patients and research locally, and examine what is involved with MDMA-assisted therapy.
Guest:
- Stephen Rush, MD, associate professor of clinical psychiatry, University of Cincinnati College of Medicine
Ways to listen to this show:
- Tune in live at noon ET M-F. Call 513-419-7100 or email talk@wvxu.org to have your voice heard on today’s topic.
- Catch the replay on 91.7 WVXU and 88.5 WMUB at 8 p.m. ET M-F.
- Listen on-demand. Audio for this segment will be uploaded to this page by 4 p.m. ET., or subscribe to our podcast.